Services on Demand
Journal
Article
English (pdf)
Article in xml format
Article references
Automatic translation
Send this article by e-mailIndicators
Cited by SciELO 
Access statistics
Related links
Cited by Google 
Similars in
SciELO 
Similars in Google
Share
Permalink
Revista Colombiana de Reumatología
Print version ISSN 0121-8123
Abstract
GUERRERO, Andrea Cevallos et al. Treatment adherence in patients with diffuse neuropsychiatrie disorders associated with systemic lupus erythematosus. Rev.Colomb.Reumatol. [online]. 2022, vol.29, n.1, pp.26-30. Epub Jan 12, 2023. ISSN 0121-8123. https://doi.org/10.1016/j.rcreu.2020.12.003.
Introduction:
Systemic lupus erythematosus (SLE) is a chronic disease that affects multiple systems and may include neurological and psychiatric events that could compromise treatment adherence and long-term outcomes in SLE.
Objective:
To evaluate treatment adherence in patients with diffuse neuropsychiatric disorders associated with SLE.
Methods:
A cross-sectional descriptive study was conducted. Treatment adherence was eval uated with the Morisky Medication Adherence Scale (MMAS-8) in patients with diffuse neuropsychiatric disorders associated with SLE (cognitive impairment, psychosis, mood disorders, and anxiety).
Results:
A total of 60 patients with neuropsychiatric disorders associated with SLE were included. Thirteen patients (21.6%) had high adherence, 9 (15%) had medium adherence, and 38 patients (63.3%) had low treatment adherence.
Conclusion:
This study has identified that almost two-thirds of the participants (63.3%) had low treatment adherence.
Keywords : Neuropsychiatry; Lupus; Adherence; Anxiety; Depression; Ecuador.
